Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10093730 Anti-interleukin-33 antibodies and uses thereof

Patent 10093730 was granted and assigned to Genentech on October, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100937300

Patent Inventor Names

Gerald R. Nakamura0

Rajita Khosla0

Wenwu Zhai0

Yi-Chun Hsiao0

Dhaya Seshasayee0

Hongkang Xi0

Jack Bevers, III0

Menno Van Lookeren Campagne0

...

Date of Patent

October 9, 2018

Patent Application Number

149377780

Date Filed

November 10, 2015

Patent Citations Received

‌

US Patent 11760797 Anti-interleukin-33 antibodies and uses thereof

‌

US Patent 12092634 Methods for quantifying IL-33

Patent Primary Examiner

‌

Joanne Hama

Patent abstract

The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10093730 Anti-interleukin-33 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API